{"filings":[{"id":2537476,"accession_number":"0001683168-26-006769","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2026-08-28T15:49:32+00:00","items":["4.01","8.01","9.01"],"status":"ready","headline":"REMSleep auditor resigns; company reviewing Q2 2026 financials for possible restatement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Fruci & Associates II resigned as auditor on July 17, 2026; no disagreements cited.","Successor PCAOB-registered auditor not yet engaged; announcement expected shortly.","Current management reviewing Q2 2026 financials for possible unrecorded liabilities and payments.","Company may amend or restate Q2 2026 financial statements; no final determination made.","Change in control and executive management transition occurred during Q2 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":844796,"accession_number":"0001213900-26-065063","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2026-06-04T13:23:06+00:00","items":["5.01","5.02","8.01","9.01"],"status":"ready","headline":"RemSleep Holdings changes control; new management team with restricted powers","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["1000152403 ONTARIO INC acquired ~80% preferred share control from Roman Wood and ~20% from Anita Michaels via private transactions; assumed ~$300K debt.","CEO, COO, Chairman, President, Treasurer, Secretary resigned effective May 27, 2026; replaced by Teresita Rubio (Chairman/Treasurer), Sanja Pekovic (CEO), Irina Veselinovic (Secretary).","Sanja Pekovic resigned as President on June 2; Peter Downey appointed Interim President with no authority to issue shares, move funds, or bind company without Secretary and Treasurer approval.","Board issued 15M restricted shares to Scott Hasselbring (executor) and 30M restricted shares to Roman Wood for past services; no cash consideration.","Company closed Georgia office, moved to Florida warehouse, shifting from retail to e-commerce; re-engaged auditor to complete late Q1 filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103760,"accession_number":"0001213900-26-023628","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Founder Thomas Wood dies; board names Anita Michaels Chairman, Jeffrey Marshall CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Founder, Chairman, and CEO Thomas Wood died on Feb. 26, 2026; he was the creator of DeltaWave® Nasal Pillow System.","Anita Michaels (sister, majority shareholder) elected Chairman; Jeffrey Marshall appointed CEO and director; Alexander Johnson also director.","New CEO Marshall receives $60k/yr base salary, increasing to $120k/yr upon $250k funding raise, plus incentive options.","Marshall eligible for up to 7% of fully diluted capitalization in stock options, with milestones including revenue targets.","Chairman Anita Michaels retains financial authority during interim; Marshall has operational authority without financial spending."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205965,"accession_number":"0001213900-24-060461","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2024-07-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Remsleep Holdings receives FDA 510(k) clearance for Deltawave CPAP Pillows Interface Mask","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA granted 510(k) clearance for the Deltawave CPAP Pillows Interface Mask on July 2, 2024.","The product is intended for use in continuous positive airway pressure therapy.","Clearance enables Remsleep to market the device in the United States.","Company expects to commence commercialization activities following the clearance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259863,"accession_number":"0001213900-23-096531","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2023-12-18T23:59:59+00:00","items":["1.01","1.02","3.02","9.01"],"status":"ready","headline":"Remsleep Holdings enters equity line with Quick Capital for up to 300M shares at 70% discount","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase agreement allows Remsleep to sell up to $100,000 per put (min $20,000) at 70% of lowest traded price over 15-day valuation period.","Quick Capital gets 3-year warrant for 15M shares at $0.015, earned upon first put notice.","Prior similar agreement with Janbella Group for 300M shares terminated on Dec 15, 2023.","Beneficial ownership limitation capped at 4.99%; puts restricted to one per 10 business days.","Purchase price floor of $0.001 per share; registration statement to be filed within 30 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277127,"accession_number":"0001213900-23-078790","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2023-09-22T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Remsleep Holdings enters equity line with Janbella for up to 300M shares at 70% market discount","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase agreement with Janbella Group for up to 300M shares over 18 months (maturity Feb 18, 2025).","Purchase price set at 70% of lowest traded price during 15-day valuation period, floor $0.001 per share.","Issued 3-year warrant to Janbella for 15M shares at $0.012 per share, earned upon first draw.","Minimum draw $20,000; maximum lower of $100,000 or 100% of avg daily volume, with 10 business days between draws.","Company to file S-1 registration statement within 30 days; beneficial ownership limited to 4.99%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277126,"accession_number":"0001213900-23-075336","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2023-09-08T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","5.01","9.01"],"status":"ready","headline":"CEO Thomas Wood receives 2M Series C Preferred shares, gaining 81% voting control, in exchange for IP assignment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company issued 2,000,000 Series C Preferred shares to CEO Thomas Wood for assignment of all IP related to the business.","Each Series C Preferred share is convertible into 300 common shares, representing 81% of combined voting power.","Amended Certificate of Designation for Series C Preferred filed July 24, 2023, granting 81% voting rights.","Assigned IP includes patents (e.g., 10,987,481; D985115) and other intellectual property listed in Exhibit A.","Transaction closed September 6, 2023; shares issued as restricted securities under Section 4(a)(2) exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277124,"accession_number":"0001213900-23-056952","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K/A","filed_at":"2023-07-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Remsleep amends 8-K to disclose Russell Bird's resignation was voluntary due to health reasons","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amendment clarifies Russell Bird's resignation (effective June 1, 2023) was voluntary and solely for an extended illness.","Mr. Bird resigned as officer and Chairman of the Board with no disagreements with the company.","Board expressed gratitude for his service and wished him continued good health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277125,"accession_number":"0001213900-23-056433","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2023-07-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Remsleep Holdings Chairman and Officer Russell Bird resigns effective June 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Russell Bird resigned all positions including officer and Chairman, effective June 1, 2023.","Bird stated no disagreements with the company; Board expressed gratitude.","No replacement named yet; CEO Thomas J. Wood signed the report."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368715,"accession_number":"0001213900-22-031914","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2022-06-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RemSleep DeltaWave reclassified as implantable by FDA; must resubmit 510K after new testing","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA reclassified DeltaWave as implantable device; company withdrawing current 510K application.","Additional testing required; RemSleep engaging consultants to satisfy new classification.","FDA confirmed all previously submitted test results will apply to the new 510K submission.","Company plans to submit next 510K for next-generation Nasal Pillows interface soon.","OTCQB application is in final stages of completion by securities attorney."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368714,"accession_number":"0001213900-22-022162","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"RemSleep Holdings moves corporate headquarters to Clearwater, Florida","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Corporate headquarters relocated to 14175 Icot Boulevard, Suite 300, Clearwater, FL 33760.","Move effective April 3, 2022, as reported in an 8-K filed April 28, 2022.","No other material changes announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":387965,"accession_number":"0001213900-22-016562","cik":1412126,"company_name":"RemSleep Holdings Inc.","ticker":"RMSL","form_type":"8-K","filed_at":"2022-03-31T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RemSleep reports cytotoxicity test failures on DeltaWave cannula; new lab to retest","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Two cytotoxicity tests on DeltaWave cannula MD, Angled Adaptor and Flexible Hose failed in early 2022.","Superior Toxicology & Wellness concluded original testing protocols were flawed and erroneous.","New third-party lab will conduct cytotoxicity tests with corrected procedures.","Initial tests by Product Safety Labs in New Jersey; both were failures.","CEO Tom Wood received letter from Dr. Joe Nieusma on March 25, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3084190.2,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}